Alternative Checkpoints as Targets for Immunotherapy

PURPOSE OF REVIEW: Immunotherapy has shown an unprecedented response in treatment of tumors. However, challenges such as lack of cytotoxic lymphocytes to mount an immune response or development of resistance to therapy can limit efficacy. Here, we discuss alternative checkpoints that can be targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Pant, Ayush, Medikonda, Ravi, Lim, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Immuno-oncology (RM Bukowski and JH Finke, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608303/
https://www.ncbi.nlm.nih.gov/pubmed/33141349
http://dx.doi.org/10.1007/s11912-020-00983-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608303/
https://www.ncbi.nlm.nih.gov/pubmed/33141349
http://dx.doi.org/10.1007/s11912-020-00983-y

Ejemplares similares